Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients

OBJECTIVE: Therapeutic drug monitoring (TDM) enables individualization in the treatment to optimize clinical benefit and minimize drugs' side effects. Critically ill septic patients represent a challenge for antimicrobial treatment because of pathophysiological impact of sepsis on pharmacokinet...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovačević, Tijana, Avram, Sanja, Milaković, Dragana, Špirić, Nikolina, Kovačević, Pedja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910469/
https://www.ncbi.nlm.nih.gov/pubmed/27330257
http://dx.doi.org/10.4103/0976-0105.183260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910469/
https://www.ncbi.nlm.nih.gov/pubmed/27330257
http://dx.doi.org/10.4103/0976-0105.183260

Ejemplares similares